The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
Signs of an inflammatory process, in particular increased pro-inflammatory cytokines and increased levels of prostaglandine E(2) (PGE(2)), have repeatedly been described in major depression (MD). As cyclooxygenase-2 (COX-2) inhibitors inhibit the PGE(2) production and the production of pro-inflammatory cytokines, we performed a therapeutic trial with the COX-2 inhibitor celecoxib. In a prospective, double-blind, add-on study, 40 patients suffering from an acute depressive episode were randomly assigned to either reboxetine and celecoxib or to reboxetine plus placebo. After a wash-out period, 20 patients received 4-10 mg reboxetine plus placebo and 20 received reboxetine plus 400 mg celecoxib for 6 weeks. The treatment effect was calculated by analysis of variance. There were no significant differences between groups in age, sex, duration or severity of disease or psychopathology, or reboxetine dose or plasma levels. Over 6 weeks, both groups of patients showed significant improvement in scores of the Hamilton Depression Scale. However, the celecoxib group showed significantly greater improvement compared to the reboxetine-alone group. Additional treatment with celecoxib has significant positive effects on the therapeutic action of reboxetine with regard to depressive symptomatology. Moreover, the fact that treatment with an anti-inflammatory drug showed beneficial effects on MD indicates that inflammation is related to the pathomechanism of the disorder, although the exact mechanisms remain to become elucidated.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Patients in the reboxetine plus celecoxib group exhibited reductions in depression severity that were nearly twice as great (55% reduction) as those experienced by patients in the control group (33% reduction).”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Müller et al., 2006
In the citing paper
“75% of patients receiving reboxetine plus celecoxib were categorized as responders, compared to only 45% of patients receiving reboxetine plus placebo”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Müller et al., 2006
In the citing paper
“TNFα antagonists such as etanercept or infliximab and the COX-2 inhibitor celecoxib have all been found to alleviate depressive symptoms in double-blind, randomized, placebo-controlled studies”
From From stress to inflammation and major depressive disorder: A social signal transduction theory of depression. (2014) · cites this paper as Müller et al., 2006
In the citing paper
“One study found positive effects on mood in medically healthy, major depressed patients.52”
From Association of depressive disorders, depression characteristics and antidepressant medication with inflammation (2012) · cites this paper as [52]
In the citing paper
“from the administration of COX2 inhibitors to patients with major depression81”
From From inflammation to sickness and depression: when the immune system subjugates the brain (2008) · cites this paper as [81]
3 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
The global burden of disease, 1990–2020
Lopez, A. D., & Murray, C. C. J. L. (1998) · Nature Medicine · doi:10.1038/3218 · Cited by 1,614
Cytokine-induced sickness behavior: where do we stand?
Dantzer, R. (2001) · Brain, Behavior, and Immunity · doi:10.1006/brbi.2000.0613 · Cited by 862
Cytokine Production and Treatment Response in Major Depressive Disorder
Lanquillon, S. (2000) · Neuropsychopharmacology · doi:10.1016/s0893-133x(99)00134-7 · Cited by 735
Maes, M., Bosmans, E., De Jongh, R., Kenis, G., Vandoolaeghe, E., & Neels, H. (1997) · Cytokine · doi:10.1006/cyto.1997.0238 · Cited by 728
Maes, M., Scharpé, S., Meltzer, H. Y., Bosmans, E., Suy, E., Calabrese, J., & Cosyns, P. (1993) · Psychiatry Research · doi:10.1016/0165-1781(93)90027-e · Cited by 439
Müller, N., Riedel, M., Scheppach, C., Brandstätter, B., Sokullu, S., Krampe, K., Ulmschneider, M., Engel, R. R., Möller, H.-J., & Schwarz, M. J. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.6.1029 · Cited by 388
Self-citationFrommberger, U. H., Bauer, J., Haselbauer, P., Fräulin, A., Riemann, D., & Berger, M. (1997) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/bf02900219 · Cited by 362
Capuron, L., Ravaud, A., Miller, A. H., & Dantzer, R. (2004) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2003.11.004 · Cited by 236
Song, C., Lin, A., Bonaccorso, S., Heide, C., Verkerk, R., Kenis, G., Bosmans, E., Scharpe, S., Whelan, A., Cosyns, P., et al. (1998) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00025-1 · Cited by 232
Cited by
Items 701–800 of 802
Molecular Pathogenesis for Schizophrenia and Major Depression
Müller, N., & Schwarz, M. (2008) · Springer eBooks · doi:10.1007/978-0-387-72573-4_36 · Cited by 1
Self-citationInflammatory Monocytes in Bipolar Disorder and Related Endocrine Autoimmune Diseases
Padmos, R. C. (2009) · RePub (Erasmus University Rotterdam) · Cited by 1
Neurochemistry immune systems interaction in depression
Myint, A.-M. (2007) · Research Publications (Maastricht University) · doi:10.26481/dis.20070118am · Cited by 3
Kynurenic acid in psychiatric disorders : studies on the mechanisms of action
Linderholm, K. R. (2010) · Figshare · Cited by 1
Firouzabadi, N., Kiafar, M., Alimoradi, N., Keshtgar, S., Mehdipour, F., & Ghods, A. (2021) · Research Square · doi:10.21203/rs.3.rs-1150729/v1 · Cited by 1
Simon, M. S. (2023) · Neuropsychiatric Disease and Treatment · doi:10.2147/ndt.s410615 · Cited by 1
Трофимов, А. Н. (2024) · Research Publications (Maastricht University) · doi:10.26481/dis.20240205at · Cited by 1
Entzündliche Veränderungen als gemeinsame Pathogenese affektiver und schizophrener Erkrankungen
Müller, N., & Schwarz, M. (2010) · Springer eBooks · doi:10.1007/978-3-211-92215-6_5 · Cited by 1
Self-citationNeuroendokrinologische und psychoneuroimmunologische Grundlagen psychischer Erkrankungen
Rupprecht, R., & Müller, N. (2007) · Springer eBooks · doi:10.1007/978-3-540-33129-2_8
Self-citationNovel Therapeutic Strategies for Bipolar Disorder
Machado‐Vieira, R., Manji, H. K., & Zarate, C. A. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch30 · Cited by 1
Major Depression and Metabolic Encephalopathy: Syndromes More Alike Than Not?
Harvey, B. H. (2008) · Springer eBooks · doi:10.1007/978-0-387-79112-8_18
Bipolar Disorder: not only in the Brain - immunological aspects
Knijff, E. M. (2006) · RePub (Erasmus University Rotterdam)
Gouzien, C., Doumy, O., & Aouizerate, B. (2015) · doi:10.1016/b978-2-294-73908-8.00004-5 · Cited by 1
Sargin, D. (2009) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-3247
Braddock, M. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.10.1725
Kitaoka, S. (2013) · Journal of Neurological Disorders · doi:10.4172/2329-6895.1000123
Müller, N. (2010) · Psychiatrie und Psychotherapie · doi:10.1007/s11326-010-0107-8
Self-citationZaminelli, T. (2013) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
LOW-FAT CRAZE FUELS DEPRESSION EPIDEMIC
Neveu, M. J. (2006)
Myint, A.-M., & Schwarz, M. (2015) · Current topics in neurotoxicity · doi:10.1007/978-3-319-13602-8_10
Self-citationPotential novel treatments for bipolar depression
Zarate, C. A., & Manji, H. K. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_12 · Cited by 1
Santos, J. E. P. (2014) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.17.2014.tde-19122014-154406
Pestana, G. (2011) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 2
Le-Niculescu, H., Balaraman, Y., Patel, S. D., Tan, J., Paulus, M. P., Kuczenski, R. T., Niculescu, A. B., McFarland, M. J., Ca, O., Za, R., et al. (2008)
Roles and Actions of Arachidonic Acid-Derived Bioactive Lipids in Stress-Related Behaviors
Furuyashiki, T., & Kitaoka, S. (2015) · Springer eBooks · doi:10.1007/978-4-431-55669-5_22
Köhler‐Forsberg, O., & Gasse, C. (2016) · Springer eBooks · doi:10.1007/978-3-319-32480-7_24 · Cited by 1
Oxidative Stress in Depression 103
Gaøecki, P. (2014)
Inflammation and cognition in major depressive disorder
Baune, B. T. (2015) · Cambridge University Press eBooks · doi:10.1017/cbo9781139860567.013
Verschlechtern NSAR den Effekt der antidepressiven Pharmakotherapie?
Müller, N. (2013) · InFo Neurologie & Psychiatrie · doi:10.1007/s15005-013-0205-4
Self-citationEinfluss von Antidepressiva auf die Zytokinproduktion depressiver Patienten in-vitro
Munzer, A. (2014) · Qucosa (Saxon State and University Library Dresden)
Möller, H. (2012)
Self-citationPsychoneuroimmunologische Grundlagen psychischer Erkrankungen
Müller, N. (2017) · Springer eBooks · doi:10.1007/978-3-662-49295-6_10
Self-citationInflammatory Mechanisms of Depression and Suicidal Behavior
Ventorp, F. (2017) · Lund University Publications (Lund University)
BIOMARKERS OF DEPRESSION: NEW CHALLENGES
Kostić-Petrović, I., & Žikić, O. (2017) · Acta Medica Medianae · doi:10.5633/amm.2017.0107
Wong, E., Krishnadas, R., & Cavanagh, J. (2013) · Advances in Psychiatric Treatment · doi:10.1192/s1355514600018770
Sherif, F. M. (2018) · Research in Medical & Engineering Sciences · doi:10.31031/rmes.2018.03.000556
Rymsha, S. V., Pypa, L. V., Svistilnik, R. V., & Лисица, Ю. Н. (2014) · CHILD`S HEALTH · doi:10.22141/2224-0551.7.58.2014.75812
Does Inflammation Link Clinical Depression and Coronary Artery Disease?
Jörgens, S., & Arolt, V. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00022-2
Self-citationIs There Still Hope for Treating Depression With Antiinflammatories?
Baune, B. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00033-7 · Cited by 1
Future Perspectives on Immune-Related Treatments
Baune, B. T. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-811073-7.00035-0
The two sides of the coin of psychosocial stress: evaluation by positron emission tomography
Feltes, P. K. (2018) · University of Groningen research database (University of Groningen / Centre for Information Technology)
Marcadores inflamatorios en depresión
Uranga, S. A. (2018) · Communities in ADDI (Universidad del Pais Vasco) · Cited by 1
Won, E., Ham, B., & Kim, Y. (2018) · Springer eBooks · doi:10.1007/978-981-10-4358-1_7
Impact, Diagnosis, Phenomenology, and Biology
Coryell, W. H. (2018) · Handbook of experimental pharmacology · doi:10.1007/164_2018_156
Chau, C. K.-L., Lau, A., Sham, P. C., & So, H.-C. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/648113
Baune, B. T. (2019) · Cambridge University Press eBooks · doi:10.1017/9781139839518.008
Rnic, K. (2019) · Scholarship@Western (Western University) · Cited by 1
Exploring Inflammatory Predictors of Depressive Responses to Exercise
Morris, B. (2019) · CU Scholar (University of Colorado Boulder)
Cakmak, J. D. (2021) · Scholarship@Western (Western University)
Potential Novel Treatments in Bipolar Depression
Machado‐Vieira, R., Henter, I. D., Manji, H. K., & Zarate, C. A. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_12
Psychoneuroendokrinologische und psychoneuroimmunologische Grundlagen psychischer Erkrankungen
Rupprecht, R., & Müller, N. (2011) · Springer eBooks · doi:10.1007/978-3-642-03637-8_9 · Cited by 1
Self-citationCurrent awareness in human psychopharmacology
(2007) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.790
Himmerich, H. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_42
Zhang, T., Yang, C., Chu, J., Ning, L., Zeng, P., Wang, X., Shi, Y., Qin, B., Qu, N., Zhang, Q., et al. (2021) · Research Square · doi:10.21203/rs.3.rs-131425/v2
Psychoneuroimmunologische Grundlagen psychischer Erkrankungen
Müller, N. (2016) · Springer eBooks · doi:10.1007/978-3-642-45028-0_10-1
Self-citationHimmerich, H., & Schneider, F. W. (2011) · Springer eBooks · doi:10.1007/978-3-642-17192-5_38
Zhang, T., Yang, C., Chu, J., Ning, L., Zeng, P., Wang, X., Shi, Y., Qin, B., Qu, N., Zhang, Q., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-131425/v1
Schram, M. T. (2018) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.726858486.793549221
Leza, J. C., Caso, J. R., & García‐Bueno, B. (2020) · doi:10.1093/med/9780198713005.003.0015
Neurobiological Principles: Psycho-Neuro-Immuno-Endocrinology
Müller, N. (2022) · Springer eBooks · doi:10.1007/978-3-030-62059-2_2
Self-citationAdeoluwa, O. A., Agboola, I., Akinluyi, E. T., Eduviere, A. T., Adeoluwa, G. O., Ajayi, A. M., & Aderibigbe, A. O. (2023) · Research Square · doi:10.21203/rs.3.rs-2022819/v1
Hypothesis of neuroinflammation in depression
Dolfi, A., & Talasman, A.-A. (2017) · Romanian Journal of Psychiatry & Psychotherapy · doi:10.37897/rjpp.2017.4.5
Implications of the inflammatory processes in major depressive episode
Purnichi, T., Grigoras, R. M., Marinescu, I. P., Parlog, M. C., Ristea, S., Paraschiv, G., Banu, R., DUICA, L. C., Manea, M. C., & Matei, V. P. (2017) · Romanian Journal of Psychiatry & Psychotherapy · doi:10.37897/rjpp.2017.1.2
Psychoneuroimmunology in Pula: A Hot Topic with a Long Past
Müller, N. (2023) · Springer eBooks · doi:10.1007/978-3-031-33013-1_15
Self-citationBinneböse, M., Schott, J., Wallis, H., Kaiser, C., & Vogel, M. (2023) · Zeitschrift für psychosomatische Medizin und Psychotherapie · doi:10.13109/zptm.2023.69.4.369
(2022) · Romanian Journal of Psychiatry & Psychotherapy · doi:10.37897/rjpp.2022.1.5
Experience with Chikujountanto (Untanto) for Trauma- and Stressor- Related Disorders
AMANO, M. (2024) · 日本東洋醫學雜誌 · doi:10.3937/kampomed.75.59
ASTIM HASTALARINDA D TİPİ KİŞİLİK, BEDENSEL DUYUMLARI ABARTMA, ANKSİYETE VE DEPRESYON BELİRTİLERİ
Yağcı, İ., & Perinçek, G. (2024) · Kocatepe tıp dergisi. · doi:10.18229/kocatepetip.1248055
Whole body vibration alleviates depressive symptoms through its anti-inflammatory effects
Duan, Y., Xiong, L., Li, J., Jiang, J., Chen, Y., Zhou, J., & Li, T. (2025) · Medical Hypotheses · doi:10.1016/j.mehy.2025.111690
Post-traumatic Stress Disorder (PTSD): Linking Inflammatory and Neural Factors
Mudgal, J., Govindula, A., & Arora, D. S. (2025) · Springer eBooks · doi:10.1007/978-3-031-73368-0_86
Hu, X., & Zhang, L. (2025) · Immune discovery. · doi:10.70322/immune.2025.10013 · Cited by 1
Samuelsson, M. (2012) · DiVA (Linkoping University)
Additional file 1 of R.ROSETTA: an interpretable machine learning framework
Garbulowski, M., Diamanti, K., Smolińska, K., Baltzer, N., Stoll, P., Bornelöv, S., Øhrn, A., Feuk, L., & Komorowski, J. (2021) · Figshare · doi:10.6084/m9.figshare.14176253
Gísladóttir, H. U. (2023) · Skemman
Causal Network Accounts Of Ill-being: Depression & Digital Well-being
Byrd, N. (2020) · PhilPapers (PhilPapers Foundation)
Lin, H. (2018) · SHAREOK (University of Oklahoma; Oklahoma State University; Central Oklahoma University) · Cited by 1
Psychosocial and Psychobiological Aspects of PCOS
Sagar, R., & Chawla, N. (2025) · BENTHAM SCIENCE PUBLISHERS eBooks · doi:10.2174/9798898810962125010021
Depresión inflamatoria: un subtipo de depresión resistente al tratamiento, revisión bibliografica
Astorga, E. D. Q. (2022) · Investigative News in Education (Universidad de Costa Rica)
Chen, Y., Zhang, Y., Huang, X., Luo, X., & Wang, H. (2026) · Dermatologic Therapy · doi:10.1155/dth/9878608
EXPLORING THE POTENTIAL ROLE OF OMEGA-3 FATTY ACIDS IN DEPRESSION
Pawelec, N., Mazur, W., Hańczyk, E., Piecuch, D., Kopciał, S., Kornatowska, K., & Drużdżel, A. (2026) · International Journal of Innovative Technologies in Social Science · doi:10.31435/ijitss.1(49).2026.5174
Pires, C. S., da Rocha, M. J., Zuge, N. P., Besckow, E. M., Gonçalves, A. S., Birmann, P. T., Pinton, S., Sousa, F. S. S., Collares, T. V., Seixas, F. K., et al. (2026) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2026.178945
Srisurapanont, M., Suradom, C., & Suttajit, S. (2026) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2026.101277
Alzoubi, L., Bseiso, Y., Gammoh, O., Aljabali, A. A. A., Salameh, B. A. B., Alqudah, A. M., Qnais, E., Al-malkawi, A. M., & Safieh, K. A. A. (2026) · Biochemistry and Biophysics Reports · doi:10.1016/j.bbrep.2026.102675
Meier, L., Mulaw, M., Durner, V., Schäfer, L., Schönfeldt‐Lecuona, C., Bopp, V., Graf, H., Otto, M., Steinacker, P., Großkopf, H., et al. (2026) · BMJ Connections Mental Health · doi:10.1136/bmjcment-2025-000016
Moschou, D., Adaïdi, H., & Stellwagen, D. (2026) · Molecular Psychiatry · doi:10.1038/s41380-026-03861-4
Calesella, F. (n.d.) · Archivio Istituzionale della Ricerca - Università Vita-Salute San Raffaele · Cited by 1
Nyland, J. J. A. O. L., Silva, A. E. A., Vianna, I. D. M., Shikanai, J. D. S., & Rocha, J. S. D. S. (2026) · Revista Científica Ipedss · doi:10.55703/27644006060403
Psychoneuroimmunologische Grundlagen psychischer Erkrankungen
Runge, K., van Elst, L. T., & Müller, N. (2026) · Springer Reference Medizin · doi:10.1007/978-3-642-45028-0_10-2
Self-citation
Metadata
- Authors
- Müller, N., Schwarz, M. J., Dehning, S., Douhe, A., Cerovecki, A., Goldstein-Müller, B., Spellmann, I., Hetzel, G., Maino, K., Kleindienst, N., Möller, H.-J., Arolt, V, & Riedel, M.
- Affiliations
- Ludwig-Maximilians-Universität München (DE)
- University of Münster (DE)
- Corresponding author
- Müller, N
- Venue
- Molecular Psychiatry
- Published
- 2006-02-21
- Volume
- 11
- Issue
- 7
- Pages
- 680-684
- ISSN
- 1359-4184 (ISSN-L)
- 1476-5578
- OpenAlex
- W2049808835
- Cited by
- 794
- References
- 37
- Citations by year
- 2026: 10 · 2025: 20 · 2024: 24 · 2023: 30 · 2022: 42 · 2021: 42 · 2020: 37 · 2019: 44 · 2018: 52 · 2017: 45 · 2016: 42 · 2015: 54 · 2014: 53 · 2013: 61 · 2012: 50
- FWCI
- 20.69
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Molecular Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Biological Psychiatry › Tryptophan and brain disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Keywords
- celecoxib, COX-2 inhibitors, major depressive disorder, reboxetine, anti-inflammatory therapy, inflammatory cytokines, prostaglandin E2, adjunctive therapy, acute depressive episode
- MeSH terms
- Celecoxib, Reboxetine, Adult, Antidepressive Agents, Depressive Disorder, Double-Blind Method, Drug Therapy, Combination, Female, Humans, Inflammation, Lorazepam, Male, Middle Aged, Morpholines, Patient Dropouts, Pilot Projects, Psychological Tests, Pyrazoles, Serotonin, Severity of Illness Index, Sulfonamides, Anti-Anxiety Agents, Dinoprostone, Interleukin-6, Adrenergic Uptake Inhibitors, Cyclooxygenase 2 Inhibitors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.